KOBAYASHI PHARMACEUTICAL CO.,LTD.

4967・Prime Market・Chemicals

Official website

KOBAYASHI PHARMACEUTICAL CO.,LTD.

4967・Prime Market・Chemicals

Official website

KOBAYASHI PHARMACEUTICAL CO.,LTD.4967

Reference Indicators

Market Cap

4,277¥100M

P/E (Forecast)

40.7x

P/B

1.9x

Dividend Yield (Forecast)

1.93%

ROE

1.7%

EV/EBITDA

15.4x

Financial Summary

Unit: ¥M

Item	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	155,252	166,258	173,455	165,600	165,742
Cost of Sales	66,478	73,927	77,079	77,997	81,030
Gross Profit	88,773	92,331	96,375	87,603	84,711
SG&A Expenses	62,707	65,662	70,595	62,742	69,788
Operating Income	26,065	26,669	25,780	24,860	14,923
Non-operating Income	2,390	2,011	2,187	2,477	2,473
Non-operating Expenses	441	399	637	476	402
Ordinary Income	28,015	28,281	27,330	26,861	16,995
Extraordinary Income	153	56	461	662	6,417
Extraordinary Losses	531	387	232	13,609	19,668
Pre-tax Income	27,636	27,950	27,559	13,914	3,744
Income Taxes	7,920	7,927	7,221	3,842	83
Net Income	19,715	20,022	20,338	10,067	3,656
EBITDA	30,900	32,027	31,837	32,882	23,668
Gross Margin	57.2%	55.5%	55.6%	52.9%	51.1%
Operating Margin	16.8%	16.0%	14.9%	15.0%	9.0%
ROA	7.8%	7.8%	7.6%	3.8%	1.3%
ROE	10.4%	10.2%	10.1%	4.8%	1.7%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
国内事業	118,064	13,963	11.8%
国際事業	46,994	810	1.7%
その他	683	215	31.5%